Cytek Biosciences CTKB
$6.12 −$0.20 (-3.16%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $6.12 0.00%
Open$6.31
Prev close$6.32
Day range$5.99 – $6.39
Volume1.77M
Market cap$800.40M
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$53.23M+1.8% YoY
Operating profit-$8.42M+8.4% YoY
Net profit-$6.10M-11.3% YoY
Diluted EPS-$0.05-25.0% YoY
Free cash flow-$6.00M-31.8% YoY
Operating cash flow-$4.45M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin54.7%
Operating margin-21.1%
Net margin-39.1%
Return on equity-23.2%
Return on assets-17.3%
Return on invested capital-22.2%
Current ratio4.46
Liabilities / assets28.0%
Cash & investments$255.90M
Total debt$21.23M
Net cash (debt)$234.67M
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $53.23M | $48.14M | $44.14M | $201.49M | $62.14M |
| Total Operating Revenue | $53.23M | $48.14M | $44.14M | $201.49M | $62.14M |
| Cost of Revenue | $22.02M | $19.80M | $22.88M | $97.03M | $29.26M |
| Gross Profit | $31.21M | $28.34M | $21.25M | $104.46M | $32.89M |
| Operating Expense | $39.63M | $39.74M | $39.72M | $144.84M | $38.48M |
| Selling and Admin Expenses | $30.27M | $30.00M | $30.11M | $108.38M | $29.52M |
| -Selling & Marketing Expense | $11.91M | $13.17M | $11.65M | $49.44M | $13.13M |
| -General & Admin Expense | $18.36M | $16.83M | $18.47M | $58.94M | $16.39M |
| Research & Development | $9.36M | $9.74M | $9.60M | $36.47M | $8.96M |
| Operating Profit | -$8.42M | -$11.40M | -$18.46M | -$40.38M | -$5.59M |
| Net Non-Operating Interest Income (Expense) | $764,000.00 | $538,000.00 | $525,000.00 | $1.74M | $1.31M |
| Non-Operating Interest Income | $1.02M | $819,000.00 | $787,000.00 | $2.22M | $580,000.00 |
| Non-Operating Interest Expense | $260,000.00 | $281,000.00 | $262,000.00 | $474,000.00 | -$725,000.00 |
| Other Income (Expense) | $751,000.00 | -$781,000.00 | $565,000.00 | $8.80M | $258,000.00 |
| Other Non-Operating Income (Expenses) | $751,000.00 | -$781,000.00 | $565,000.00 | $8.80M | $258,000.00 |
| Pretax Profit | -$6.91M | -$11.64M | -$17.37M | -$29.84M | -$4.03M |
| Tax | -$811,000.00 | $515,000.00 | $1.49M | $36.70M | $40.05M |
| Net Profit | -$6.10M | -$12.16M | -$18.87M | -$66.54M | -$44.08M |
| Profit from Continuing Operations | -$6.10M | -$12.16M | -$18.87M | -$66.54M | -$44.08M |
| Net Income to Parent Company | -$6.10M | -$12.16M | -$18.87M | -$66.54M | -$44.08M |
| Net Income to Common Stockholders | -$6.10M | -$12.16M | -$18.87M | -$66.54M | -$44.08M |
| Basic EPS | -$0.05 | -$0.09 | -$0.15 | -$0.52 | -$0.34 |
| Diluted EPS | -$0.05 | -$0.09 | -$0.15 | -$0.52 | -$0.34 |
| Minority Interests | – | – | – | $0.00 | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $446.15M | $446.93M | $449.11M | $461.54M | $461.54M |
| Total Current Assets | $378.94M | $377.93M | $379.30M | $392.00M | $392.00M |
| Cash and Cash Equivalents & Short-Term Investments | $255.90M | $262.00M | $262.23M | $261.53M | $261.53M |
| -Cash and Cash Equivalents | $66.81M | $73.85M | $65.67M | $90.85M | $90.85M |
| -Short Term Investments | $189.09M | $188.16M | $196.56M | $170.68M | $170.68M |
| Receivables | $60.78M | $51.30M | $56.48M | $72.13M | $72.13M |
| -Accounts Receivable | $59.19M | $49.70M | $51.90M | $62.51M | $62.51M |
| -Taxes Receivable | $1.01M | $1.02M | $1.02M | $5.41M | $5.41M |
| -Other Receivables | $575,000.00 | $582,000.00 | $3.56M | $4.21M | $4.21M |
| Prepaid Assets | $6.81M | $6.90M | $7.21M | $6.94M | $6.94M |
| Inventory | $52.37M | $52.25M | $49.79M | $48.43M | $48.43M |
| Restricted Cash | $385,000.00 | – | – | $0.00 | $0.00 |
| Other Current Assets | $2.69M | $5.48M | $3.60M | $2.98M | $2.98M |
| Total Non-Current Assets | $67.21M | $69.00M | $69.81M | $69.55M | $69.55M |
| Net PPE | $30.94M | $31.76M | $31.11M | $29.32M | $29.32M |
| -Gross PPE | $46.31M | $45.99M | $44.17M | $41.46M | $41.46M |
| -Accumulated Depreciation | -$15.37M | -$14.22M | -$13.06M | -$12.13M | -$12.13M |
| Goodwill and Other Intangible Assets | $30.72M | $31.56M | $32.39M | $33.52M | $33.52M |
| -Goodwill | $16.69M | $16.69M | $16.69M | $16.70M | $16.70M |
| -Other Intangible Assets | $14.03M | $14.87M | $15.70M | $16.82M | $16.82M |
| Other Non-Current Assets | $5.55M | $5.69M | $6.31M | $6.70M | $6.70M |
| Total Liabilities | $124.79M | $124.98M | $121.47M | $119.80M | $119.80M |
| Total Current Liabilities | $84.95M | $84.34M | $80.94M | $77.80M | $77.80M |
| Payables | $11.13M | $14.76M | $13.77M | $12.69M | $12.69M |
| -Accounts Payable | $4.89M | $8.41M | $6.74M | $6.41M | $6.41M |
| -Total Tax Payable | $6.25M | $6.35M | $7.03M | $6.28M | $6.28M |
| Current Accrued Expenses | $13.90M | $11.75M | $11.71M | $8.23M | $8.23M |
| Short-Term Debt and Capital Lease Obligation | $11.81M | $12.70M | $13.66M | $9.18M | $9.18M |
| -Current Debt | $8.35M | $9.43M | $10.71M | $6.30M | $6.30M |
| -Current Capital Lease Obligation | $3.46M | $3.27M | $2.94M | $2.88M | $2.88M |
| Current Deferred Liabilities | $32.07M | $30.32M | $31.18M | $29.57M | $29.57M |
| Other Current Liabilities | $2.79M | $2.70M | $2.55M | $2.95M | $2.95M |
| Total Non-Current Liabilities | $39.84M | $40.65M | $40.53M | $42.00M | $42.00M |
| Long Term Debt and Capital Lease Obligation | $12.88M | $13.76M | $13.83M | $14.57M | $14.57M |
| -Long Term Debt | $99,000.00 | $246,000.00 | $386,000.00 | $525,000.00 | $525,000.00 |
| -Long Term Capital Lease Obligation | $12.78M | $13.52M | $13.44M | $14.04M | $14.04M |
| Non-Current Deferred Liabilities | $18.74M | $18.06M | $17.67M | $18.34M | $18.34M |
| Other Non-Current Liabilities | $8.22M | $8.82M | $9.04M | $9.09M | $9.09M |
| Total Equity | $321.35M | $321.95M | $327.64M | $341.74M | $341.74M |
| Stockholders' Equity | $321.35M | $321.95M | $327.64M | $341.74M | $341.74M |
| Capital Stock | $131,000.00 | $130,000.00 | $129,000.00 | $129,000.00 | $129,000.00 |
| -Common Stock | $131,000.00 | $130,000.00 | $129,000.00 | $129,000.00 | $129,000.00 |
| Additional Paid-In Capital | $457.44M | $451.85M | $445.75M | $441.11M | $441.11M |
| Retained Earnings | -$138.86M | -$132.76M | -$120.60M | -$101.74M | -$101.74M |
| Gains/Losses Not Affecting Retained Earnings | $2.64M | $2.74M | $2.37M | $2.24M | $2.24M |
| Non-Current Deferred Assets | – | – | – | $0.00 | $0.00 |
| Minority Interests | – | – | – | $0.00 | $0.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$4.45M | $1.37M | -$2.74M | -$4.69M | -$771,000.00 |
| Net cash flow from continuing operations | -$4.45M | $1.37M | -$2.74M | -$4.69M | -$771,000.00 |
| Net Income from Continuing Operations | -$6.10M | -$12.16M | -$18.87M | -$66.54M | -$44.08M |
| Gain/Loss from Continuing Operations | -$830,000.00 | -$1.16M | -$1.20M | -$5.26M | -$1.15M |
| Depreciation & Depletion & Amortization | $3.11M | $2.99M | $2.81M | $11.98M | $3.04M |
| Deferred Tax | $0.00 | $0.00 | -$183,000.00 | $33.56M | $38.58M |
| Other Non-Cash Items | -$134,000.00 | $1.68M | $189,000.00 | -$328,000.00 | -$761,000.00 |
| Change in Working Capital | -$5.89M | $4.19M | $9.00M | -$4.79M | -$3.48M |
| -Change in Receivables | -$10.08M | $1.97M | $9.65M | $368,000.00 | -$6.15M |
| -Change in Inventory | -$222,000.00 | -$2.86M | -$1.63M | -$5.24M | $2.05M |
| -Change in Prepaid Assets | $3.14M | -$2.25M | $3.85M | -$2.66M | -$3.35M |
| -Change in Payables and Accrued Expense | $698,000.00 | $5.86M | -$3.50M | $4.42M | $3.40M |
| -Change in Other Current Liabilities | -$1.17M | $1.87M | -$548,000.00 | -$5.28M | -$1.16M |
| -Change In Other Working Capital | $1.75M | -$400,000.00 | $1.18M | $3.60M | $1.74M |
| Net cash flow from investing | -$1.80M | $7.02M | -$27.08M | $10.12M | -$1.84M |
| Net Cash Flow from Continuing Investing Activities | -$1.80M | $7.02M | -$27.08M | $10.12M | -$1.84M |
| Net PPE Purchase and Sale | -$1.44M | -$2.21M | -$2.16M | -$3.83M | -$806,000.00 |
| Net Intangibles Purchase and Sale | -$42,000.00 | -$28,000.00 | -$33,000.00 | -$106,000.00 | -$32,000.00 |
| Net Investment Purchase and Sale | -$323,000.00 | $9.26M | -$24.88M | $14.06M | -$1.00M |
| Financing Cash Flow | -$561,000.00 | -$814,000.00 | $3.98M | -$13.43M | -$1.23M |
| Net Cash Flow from Continuing Financing Activities | -$561,000.00 | -$814,000.00 | $3.98M | -$13.43M | -$1.23M |
| Net Issuance Payments Of Debt | -$1.31M | -$1.57M | $4.20M | $837,000.00 | -$1.52M |
| Net Common Stock Issuance | $0.00 | $0.00 | $0.00 | -$15.07M | $34,000.00 |
| Proceeds from Stock Option Exercised | $1.01M | $942,000.00 | $21,000.00 | $1.47M | $531,000.00 |
| Net Other Financing Charges | -$264,000.00 | -$184,000.00 | -$239,000.00 | -$669,000.00 | -$267,000.00 |
| Ending Cash Balance | $67.19M | $73.85M | $65.67M | $90.85M | $90.85M |
| Net Change in Cash | -$6.81M | $7.58M | -$25.83M | -$8.00M | -$3.84M |
| Beginning Cash Balance | $73.85M | $65.67M | $90.85M | $98.75M | $93.28M |
| Effect of Exchange Rate Changes | $158,000.00 | $606,000.00 | $646,000.00 | $109,000.00 | $1.41M |
| Free Cash Flow | -$6.00M | -$877,000.00 | -$4.94M | -$8.88M | -$1.80M |
| Net Business Purchase and Sale | – | – | – | $0.00 | – |
| Net Other Investing Changes | – | – | – | -$1,000.00 | – |
No comments yet — be the first to weigh in on CTKB.
Sign in to join the discussion.